Updated on 2025/06/24

Information

 

写真a

 
MORI TARO
 
Organization
Faculty of Medical Sciences Department of Basic Medicine Assistant Professor
Graduate School of Medical Sciences Department of Health Care Administration and Management(Concurrent)
School of Medicine Department of Medicine(Concurrent)
Title
Assistant Professor
Contact information
メールアドレス
Tel
0926426072
External link

Research Areas

  • Life Science / Human pathology

Degree

  • Mar 2023 Kyushu University, Philosophy of doctor (medical science)

Research History

  • Kyushu University Faculty of Medical Sciences Department of Basic Medicine  Assistant Professor 

    2023.4 - Present

Education

  • Kyushu University   大学院医学研究院  

    2019.4 - 2023.3

  • Shinshu University   医学部   医学科

    2007.4 - 2013.3

Research Interests・Research Keywords

  • Research theme: Elucidation of therapeutic targets and prognostic factors in bone and soft tissue tumors

    Keyword: Bone and soft tissue, Pathology

    Research period: 2023.4 - 2027.3

Papers

  • <i>DDIT3</i>-amplified or low-polysomic pleomorphic sarcomas without<i> MDM2</i> amplification: Clinicopathological review and immunohistochemical profile of nine cases Reviewed International journal

    Mori, T; Iwasaki, T; Sonoda, H; Kawaguchi, K; Tomonaga, T; Furukawa, H; Sato, C; Shiraishi, S; Taguchi, K; Tamiya, S; Yoneda, R; Oshiro, Y; Matsunobu, T; Abe, C; Kuboyama, Y; Ueki, N; Kohashi, K; Yamamoto, H; Nakashima, Y; Oda, Y

    HUMAN PATHOLOGY   145   56 - 62   2024.3   ISSN:0046-8177 eISSN:1532-8392

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Human Pathology  

    Several high-grade pleomorphic sarcoma cases that cannot be classified into any existing established categories have been reported. These cases were provisionally classified into undifferentiated pleomorphic sarcoma (UPS). Some dedifferentiated liposarcoma (DDLS) cases may also have been classified into the UPS category due to the absence of MDM2 amplification or an atypical lipomatous tumor/well-differentiated liposarcoma component. We retrieved and reviewed 77 high-grade pleomorphic sarcoma cases, initially diagnosed as UPS in 66 cases and DDLS in 11 cases. Fluorescence in situ hybridization (FISH) analyses of DDIT3 and MDM2 were performed for available cases. Of the cases successfully subjected to DDIT3 FISH (n = 56), nine (7 UPS and 2 DDLS) showed DDIT3 amplification but no MDM2 amplification. Two UPS cases showed both telomeric (5′) and centromeric (3′) amplification of DDIT3 or low polysomy of chromosome 12, whereas 5 UPS and 2 DDLS cases showed 5′-predominant DDIT3 amplification. Histopathologically, all cases showed UPS-like proliferation of atypical pleomorphic tumor cells. Immunohistochemically, only one case showed focal nuclear positivity for DDIT3, supporting the previous finding that DDIT3 expression was not correlated with DDIT3 amplification. All three cases with focal MDM2 expression involved 5′-predominant amplification, two of which showed DDLS-like histological features. The majority of cases (7/9) showed decreased expression in p53 staining, suggesting that DDIT3 amplification regulates the expression of TP53 like MDM2. From a clinicopathological perspective, we hypothesize that DDIT3-amplified sarcoma, especially with 5′-predominant amplification, can be reclassified out of the UPS category.

    DOI: 10.1016/j.humpath.2024.02.007

    Web of Science

    Scopus

    PubMed

  • Clinicopathological and histopathological review of dedifferentiated liposarcoma: a comprehensive study of 123 primary tumours. Reviewed International journal

    Mori T, Yamada Y, Kinoshita I, Kohashi K, Yamamoto H, Ito Y, Susuki Y, Kawaguchi K, Nakashima Y, Oda Y

    HISTOPATHOLOGY   80 ( 3 )   538 - 557   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Aims: Dedifferentiated liposarcoma (DDLS) has varying histopathological features, but their significance for the biological behaviour of this disease has not been fully clarified. The aim of this study was to elucidate the prognostic factors for DDLS by clinicopathologically reviewing a large case series.
    Methods and results: We clinicopathologically reviewed 123 cases of primary de-novo DDLS without preoperative treatment, including 81 in the internal trunk (internal DDLS) and 42 in peripheral sites (peripheral DDLS). Univariate and multivariate analyses of their features were also performed for all cases, the internal DDLS group, and the peripheral DDLS group. The results showed that, in all three groups, distant metastasis was significantly associated with shorter overall survival (OS) (univariate analysis, P < 0.0001, P = 0.0011, and P = 0.0101, respectively), whereas local recurrence showed no significant effect on prognosis. Histopathologically, a high mitotic count and the presence of round tumour cells were significantly associated with shorter OS in multivariate analysis of the internal DDLS group [respectively: P = 0.0022, hazard ratio (HR) 4.39, 95% confidence interval (CI) 1.71-11.28; and P = 0.0014, HR 7.19, 95% CI 2.14-24.16]. In the peripheral DDLS group, necrosis and high-grade histological components were significantly associated with shorter OS (univariate analysis, P = 0.0068 and P = 0.0174, respectively).
    Conclusions: The presence of round tumour cells may be one of the histological factors associated with a worse prognosis of DDLS patients, as previous studies indicated. This study also suggests that distant metastasis may be predictive of prognosis for both internal and peripheral DDLS, rather than local recurrence.

    DOI: 10.1111/his.14588.

  • Squamous cell carcinoma arising in sacrococcygeal teratoma in an adult: A case report Reviewed

    Tanaka, Y; Nakanishi, R; Hazama, H; Mori, T; Kawazoe, T; Kudou, K; Zaitsu, Y; Hisamatsu, Y; Ando, K; Oki, E; Aishima, S; Oda, Y; Yoshizumi, T

    HUMAN PATHOLOGY REPORTS   40   2025.6   eISSN:2772-736X

     More details

    Language:English   Publisher:Human Pathology Reports  

    Sacrococcygeal teratomas (SCT) with malignant transformation to squamous cell carcinoma are extremely rare, with only few cases reported in the literature. Herein, we report on a case of a primary sacrococcygeal mature cystic teratoma with malignant transformation into a squamous cell carcinoma. A 53-year-old woman presented with dysuria and lower abdominal pain caused by a huge SCT. Computed tomography (CT), magnetic resonance imaging, and positron emission tomography/CT findings were suggestive of SCT with malignant transformation. The treatment involved robotic-assisted laparoscopic abdominoperineal resection and bilateral lymph node dissection. Histopathology revealed squamous cell carcinoma within the teratoma. Postoperatively, the patient underwent six cycles of paclitaxel-carboplatin chemotherapy and showed no signs of recurrence during the 1-year follow-up.

    DOI: 10.1016/j.hpr.2025.300773

    Web of Science

    Scopus

  • Impact of Tertiary Lymphoid Structure on Prognosis and Tumor Microenvironment in Undifferentiated Pleomorphic Sarcoma Reviewed

    Sonoda, H; Iwasaki, T; Ishihara, S; Mori, T; Nakashima, Y; Oda, Y

    CANCER SCIENCE   116 ( 5 )   1464 - 1473   2025.5   ISSN:1347-9032 eISSN:1349-7006

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Cancer Science  

    Undifferentiated pleomorphic sarcoma (UPS) has a favorable objective response rate to anti-PD-1 drugs compared with other sarcomas. Tertiary lymphoid structure (TLS) is a favorable prognostic factor and a biomarker for immune checkpoint inhibitors (ICIs). Nevertheless, there are limited data on the tumor microenvironment (TME) to support a good response to ICIs in sarcoma. Therefore, this study was conducted to investigate the impact of TLS on prognosis and TME. A total of 52 of UPS with wide resection were divided into intratumoral TLS, extratumoral TLS, and without TLS groups. Survival analysis and immunohistochemistry were performed to evaluate immune cells and immune checkpoint molecules, and multiplexed immunofluorescence was conducted to evaluate T-cell exhaustion among the three groups. TLS was detected in 34 cases (65%), including 23 intratumoral TLS (44%) and 11 extratumoral TLS (21%) cases. Patients with TLS had significantly longer overall survival than those without TLS (log rank p = 0.020). The intratumoral TLS group had a significantly higher number of immune cells and higher expression of PD-L1 and IDO-1 than the without TLS group. Progenitor-exhausted T cells were also observed in patients with UPS. In conclusion, these findings could help predict prognosis in patients with UPS. TLS was demonstrated to be a favorable prognostic factor in patients with UPS. Intratumoral TLS may be a biomarker for the response to ICIs, especially anti-PD-1 drugs.

    DOI: 10.1111/cas.70018

    Web of Science

    Scopus

    PubMed

  • Soft tissue tumor with <i>BRAF</i> and <i>NRAS</i> mutations sharing features with <i>NTRK</i>-rearranged spindle cell neoplasm: A case report expanding the spectrum of spindle cell tumor with kinase gene alterations Reviewed

    Kakuda, Y; Kato, I; Kawata, T; Goto, K; Ito, K; Satake, R; Toki, S; Murata, H; Wasa, J; Katagiri, H; Takahashi, M; Nagashima, T; Mori, T; Oda, Y; Sugino, T; Yamaguchi, K

    PATHOLOGY INTERNATIONAL   75 ( 1 )   40 - 45   2025.1   ISSN:13205463 eISSN:1440-1827

     More details

    Language:English   Publisher:Pathology International  

    NTRK-rearranged spindle cell neoplasm is a group of tumors characterized by NTRK1/2/3 gene fusion. Recently, tumors with other kinase fusion genes were reported to exhibit similar morphologies. Herein, we discuss an adult-onset soft tissue tumor with similar histologic patterns as kinase gene fusion-related tumors but with BRAF and NRAS mutations. A female in her 40s had a 40 mm tumor with an unclear border in the soft tissue of her foot joint. Short spindle-shaped tumor cell proliferation with abundant capillaries and collagen fiber bundles were observed. The tumor infiltrated the subcutaneous adipose tissue, exhibiting a lipofibromatosis-like pattern. Immunohistochemically, the tumor cells coexpressed CD34, S-100, and BRAF V600E. Whole-exome sequencing revealed BRAF p.V600E and NRAS p.Q61K mutations. Since BRAF activation occurs in BRAF fusion gene tumors and BRAF mutations, they could share a similar mechanism in tumorigenesis. This case suggests the further expansion of kinase-related spindle cell tumors.

    DOI: 10.1111/pin.13499

    Web of Science

    Scopus

    PubMed

  • A case of malignant spindle cell tumor of skull with BRAF V600E mutation Reviewed International journal

    Tsuchihashi, K; Nishiyori, S; Kusumoto, Y; Yoshihiro, T; Arimizu, K; Sangatsuda, Y; Komune, N; Hisano, O; Yoshitake, T; Hazama, H; Mori, T; Yoshimoto, K; Oda, Y; Akashi, K; Baba, E

    CANCER SCIENCE   116   380 - 380   2025.1   ISSN:1347-9032 eISSN:1349-7006

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  • Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis Reviewed

    Izumi, R; Hashimoto, T; Kisanuki, H; Ikuta, K; Otsuru, W; Asakawa, S; Yamamoto, S; Misumi, K; Fujino, T; Shinohara, K; Matsushima, S; Hosokawa, K; Katsuki, S; Mori, T; Hashisako, M; Tateishi, Y; Iwasaki, T; Oda, Y; Kinugawa, S; Abe, K

    CARDIO-ONCOLOGY   10 ( 1 )   82   2024.11   eISSN:2057-3804

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Cardio Oncology  

    The advent of immune checkpoint inhibitors (ICIs) has significantly improved cancer treatment. With the increasing use of ICIs, ICI-related myocarditis has been recognized. However, an evidence-based therapeutic strategy has not been established because of the limited knowledge on ICI-related myocarditis. Here, we present four cases of ICI-related fulminant myocarditis (FM). Three of the four cases resulted in fatal outcomes despite aggressive treatment with mechanical circulatory support and immunosuppressive therapy with corticosteroids. Given the poor prognosis of ICI-FM, the establishment of rapid and adequate therapeutic interventions on the basis of clinical and pathological evaluation is imperative.

    DOI: 10.1186/s40959-024-00288-0

    Web of Science

    Scopus

    PubMed

  • Reappraisal of bone and soft tissue cytopathology classification using the modified Milan system Reviewed

    Naka, M; Yamamoto, H; Kohashi, K; Iwasaki, T; Mori, T; Nogami, M; Ookubo, F; Higuchi, K; Motoi, T; Oda, Y

    CANCER CYTOPATHOLOGY   132 ( 11 )   696 - 706   2024.11   ISSN:1934-662X eISSN:1934-6638

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Cancer Cytopathology  

    Background: A standardized reporting system for bone and soft tissue tumor cytopathology has not yet been established. The objective of this study was to explore the potential utility of a classification modified from the Milan System for Salivary Gland Cytopathology and compared it with the upcoming World Health Organization (WHO) system for fine-needle aspiration of soft tissue lesions. Methods: The authors reviewed 285 cytology cases of bone/joint (n = 173) and soft tissue (n = 112) lesions, scoring each within diagnostic categories. The results were compared with histologic diagnoses and the risk of malignancy (ROM) for each category, and diagnostic reliability was analyzed. Results: All 285 cases were successfully classified into one of the following categories: nondiagnostic (6.3%), non-neoplastic (11.9%), atypia of uncertain significance (11.9%), benign neoplasm (5.6%), bone and soft tissue neoplasm of uncertain malignant potential (25.3%), suspicious for malignancy (1.4%), and malignant (37.5%). The ROM was 44.4% (eight of /18 cases) in nondiagnostic, 0% (zero of 34 cases) in non-neoplastic, 32.4% (11 of 34 cases) in atypia of uncertain significance, 0% (zero of 16 cases) in benign neoplasm, 16.7% (12 of 72 cases) in bone and soft tissue neoplasm of uncertain malignant potential, 75.0% (three of four cases) in suspicious for malignancy, and 100% (107 of 107 cases) in malignant categories. Using the WHO system, the proportion and ROM of the benign category (non-neoplastic and benign neoplasm) was 17.5% and 0%, respectively. Among benign and malignant lesions, the diagnostic accuracy, sensitivity, and specificity for detecting malignancy were 99.4%, 100%, and 98.0%, respectively. Conclusions: The modified Milan system as well as the WHO system may be a useful cytopathologic classification tool for both bone and soft tissue lesions.

    DOI: 10.1002/cncy.22888

    Web of Science

    Scopus

    PubMed

  • Prognostic implications of the immunohistochemical expression of perilipin 1 and adipophilin in high-grade liposarcoma Reviewed International journal

    Kawaguchi, K; Kohashi, K; Mori, T; Yamamoto, H; Iwasaki, T; Kinoshita, I; Susuki, Y; Furukawa, H; Endo, M; Matsumoto, Y; Nakashima, Y; Oda, Y

    JOURNAL OF CLINICAL PATHOLOGY   77 ( 10 )   676 - 682   2024.10   ISSN:0021-9746 eISSN:1472-4146

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Journal of Clinical Pathology  

    Aims Liposarcoma is a malignant soft tissue tumour with adipocytic differentiation. Dedifferentiated liposarcoma (DDLS) and myxoid liposarcoma (MLS) are classified as high-grade liposarcomas. Lipid droplet-associated protein (also known as perilipin 1 (PLIN1)) is the predominant perilipin and has utility as a specific marker of adipogenic differentiation. Adipose differentiation-related protein (also known as adipophilin (ADRP)) is ubiquitously expressed in a range of tissues. High ADRP expression is reportedly a poor prognostic factor in several cancer types. However, no previous studies have examined the association between PLIN1 or ADRP expression and prognosis in sarcoma. This study therefore aimed to evaluate the association between PLIN1 or ADRP expression and prognosis in liposarcoma. Methods In total, 97 primary resection specimens (53 MLS and 44 DDLS) were examined in this study. PLIN1 and ADRP expression was evaluated by immunohistochemistry. Survival analyses were performed for MLS and DDLS. Results Of the 53 MLS specimens, 15 (28.3%) exhibited high PLIN1 expression. PLIN1 expression was not observed in DDLS specimens. High PLIN1 expression was significantly associated with increased disease-free survival (DFS) among patients with MLS (p=0.045). Distinct ADRP expression was observed in 13 of 53 (24.5%) MLS specimens and 5 of 44 (11.4%) DDLS specimens. High ADRP expression was associated with shorter overall survival (OS) in MLS (p=0.042) and DFS and shorter OS in DDLS (p=0.024 and p<0.001, respectively). Conclusions PLIN1 and ADRP expression is associated with poor prognosis in high-grade liposarcoma.

    DOI: 10.1136/jcp-2023-208814

    Web of Science

    Scopus

    PubMed

  • 胸壁に発生した筋肉内血管腫の切除例 症例報告(Resected intramuscular hemangioma in the chest wall: a case report)

    Nakanishi Yoshiyuki, Akamine Takaki, Kinoshita Fumihiko, Kohno Mikihiro, Ozono Keigo, Hino Takuya, Mori Taro, Oda Yoshinao, Takenaka Tomoyoshi, Nakamura Masafumi

    Surgical Case Reports   10   s40792 - 024   2024.9

     More details

    Language:English   Publisher:(一社)日本外科学会  

    症例は29歳男性で、定期検診時の胸部X線検査で右肺野に異常陰影がみられた。腫瘍マーカーを含む血液検査は正常であったが、CTでは第2肋間内に30mm大の境界明瞭な腫瘤を認め、MRIでもT2強調画像で高信号、T1強調画像で中程度の信号がみられた。神経鞘腫または孤発性線維性腫瘍が疑われたため、診断と治療を目的に胸腔鏡下手術を行った。腫瘍は第2肋軟骨前方の胸壁に認められ、表面は滑らかで胸膜と内側肋間筋に覆われていた。胸膜壁を腫瘍境界に沿って切開し、腫瘍を外側肋間筋および肋骨から剥離した。術後の病理組織学的検査では、毛細血管構造に配列された紡錘形の内皮細胞の増殖が認められ、これに伴って平滑筋線維、脂肪組織、筋肉血管が取り込まれていた。最終的に、切除断端陰性の筋肉内血管腫と診断した。術後経過は良好で、5日後に退院し、術後12ヵ月時点で再発の徴候は認められていない。

  • HER2陽性進行胃癌切除後2年で単独脳転移を呈した1例

    新垣 滉大, 大内田 研宙, 堤 親範, 進藤 幸治, 森山 大樹, 藤岡 寛, 下川 能史, 松本 崇雅, 毛利 太郎, 田村 公二, 永吉 絹子, 池永 直樹, 仲田 興平, 吉本 幸司, 小田 義直, 中村 雅史

    日本消化器外科学会雑誌   57 ( 7 )   326 - 333   2024.7   ISSN:0386-9768

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    症例は75歳の男性で,2020年進行胃癌に対して腹腔鏡下胃全摘術を施行した.病理診断で口側断端にリンパ管侵襲を認め非治癒切除と判断した.免疫染色検査でHER2[3+]であり,術後化学療法としてトラスツズマブ+カペシタビン+シスプラチン療法8コースとカペシタビン単剤療法を16コース施行した.術後約2年で左下肢の脱力感および転倒のため近医搬送となった.CTで転移性脳腫瘍を指摘され当院へ転院となった.その他の転移はなく,脳神経外科で開頭腫瘍摘出術を施行した.術後病理より胃癌の転移性腫瘍と判断した.トラスツズマブ投与後の頭蓋内単独再発例であったため,頭蓋内も含めた全身の治療効果を期待してニボルマブ単独投与を行い,術後6ヵ月現在無再発経過中である.今回,我々はHER2陽性進行胃癌の切除後に抗HER2療法を行い,その後に単独脳転移を呈した1例を経験したため報告する.(著者抄録)

  • Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review

    Yamamoto, Y; Shibahara, D; Mori, T; Otsubo, K; Shiraishi, Y; Yoneshima, Y; Iwama, E; Tanaka, K; Oda, Y; Okamoto, I

    THORACIC CANCER   15 ( 13 )   1106 - 1111   2024.5   ISSN:1759-7706 eISSN:1759-7714

     More details

    Language:English   Publisher:Thoracic Cancer  

    Tracheomediastinal fistula is a rare but life-threatening complication of cancer. We report a case of tracheomediastinal fistula induced by concurrent chemoradiotherapy in limited stage small cell lung cancer. Despite the treatment response, the metastatic paratracheal lymph node increased gradually during concurrent chemoradiotherapy, resulting in the occurrence of tracheomediastinal fistula and mediastinitis. Without any surgical intervention, the patient achieved successful recovery from mediastinitis through antibiotic treatment, although the tracheomediastinal fistula remained open. In this report, we also review previous studies of tracheomediastinal and bronchomediastinal fistulas and summarize the clinical features.

    DOI: 10.1111/1759-7714.15270

    Web of Science

    Scopus

    PubMed

  • Nuclear morphological atypia in biopsy accurately reflects the prognosis of myxoid liposarcoma. Reviewed International journal

    Kawaguchi K, Kohashi K, Iwasaki T, Mori T, Furukawa H, Sato C, Sonoda H, Shiraishi S, Endo M, Nakashima Y, Oda Y.

    Virchows Archiv   486 ( 2 )   373 - 380   2024.3   ISSN:0945-6317 eISSN:1432-2307

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Virchows Archiv  

    Currently, it is difficult to predict the prognosis of myxoid liposarcoma (MLS) in biopsy specimens. In this study, we determined whether nuclear morphology may be used to predict the prognosis of MLS in primary biopsy specimens. Two pathologists evaluated nuclear morphology using the modified WHO/ISUP and Fuhrman grades. Survival analyses were performed by grouping nuclear high- and low-grades. We examined 53 MLS cases, which included 29 (54.7%) male and 24 (45.3%) female patients with a median age of 46 years (interquartile range, 37 - 60). In total, 7 (13.2%) and 16 (30.2%) cases were assigned to the high nuclear grade group based on the modified WHO/ISUP and Fuhrman gradings, respectively. Survival analyses revealed a significantly worse disease-free survival in the high-grade group (hazard ratio (HR), 7.51; 95% confidence interval (CI), 2.67-21.1, p < 0.001 by the modified WHO/ISUP grading; HR, 4.45; 95% CI, 1.63-12.1, p = 0.001 by the modified Fuhrman grading). Moreover, the modified WHO/ISUP grade showed a significantly worse overall survival in the high-grade group (HR, 4.39; 95% CI, 1.04-18.6, p = 0.028), and the modified Fuhrman grade exhibited a similar, but not significant, trend. Our results indicate that nuclear morphology grading is a good predictor of patient prognosis at the time of biopsy in MLS. Even when cell density is sparse, treatment strategies should be carefully considered when individual tumor cells exhibit atypical nuclei.

    DOI: 10.1007/s00428-024-03796-7

    Web of Science

    Scopus

    PubMed

  • Subcutaneous Thyroid Tissue Implantation after Thyroidectomy: A Mimic of Benign Cutaneous Tumours Reviewed

    Takei, I; Ito, T; Mori, T; Oda, Y; Nakahara, T

    ACTA DERMATO-VENEREOLOGICA   103   adv00842   2023   ISSN:0001-5555 eISSN:1651-2057

     More details

    Language:English   Publisher:Acta Dermato Venereologica  

    DOI: 10.2340/actadv.v103.4407

    Web of Science

    Scopus

    PubMed

  • Myxoid type and non-myxoid type of intimal sarcoma in large vessels and heart: review of histological and genetic profiles of 20 cases Reviewed

    Yamada, Y; Kinoshita, I; Miyazaki, Y; Tateishi, Y; Kuboyama, Y; Iwasaki, T; Kohashi, K; Yamamoto, H; Ishihara, S; Toda, Y; Ito, Y; Susuki, Y; Kawaguchi, K; Hashisako, M; Yamada-Nozaki, Y; Kiyozawa, D; Mori, T; Yamamoto, T; Tsuchihashi, K; Kuriwaki, K; Mukai, M; Kawai, M; Suzuki, K; Nishimura, H; Bando, K; Masumoto, J; Fukushima, M; Motoshita, J; Mori, H; Shiose, A; Oda, Y

    VIRCHOWS ARCHIV   480 ( 4 )   919 - 925   2022.4   ISSN:0945-6317 eISSN:1432-2307

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Virchows Archiv  

    Intimal sarcoma is one of the most common and well-known primary malignant neoplasms of the aorta and heart. The authors reviewed cases of intimal sarcoma from histological, immunohistochemical and genetic perspectives. Twenty cases of intimal sarcoma were retrieved. Immunohistochemistry and FISH of MDM2 and PDGFRA genes were performed. All 20 tumours were composed of spindle-shaped, stellate, oval or polygonal tumour cells with irregular hyperchromatic nuclei arranged in a haphazard pattern, accompanied by nuclear pleomorphism and frequent mitotic figures. Other histological findings were as follows: abnormal mitosis in 10 cases (50%), necrosis in 15 cases (75%), myxoid stroma in 12 cases (60%), cartilaginous formation in 1 case (5%), haemorrhage in 12 cases (60%) and fibrinous deposition in 14 cases (70%). The tumours were positive for MDM2 in 16 cases (80%), ERG in 4 cases (20%), alpha-smooth muscle actin in 6 cases (30%), desmin in 5 cases (25%) and AE1/AE3 in 4 cases (20%). Immunohistochemical positivity was focal in each case. Loss of H3K27me3 expression was noted in 2 cases (10%). MDM2 and PDGFRA gene amplifications were detected in 11 cases (55%) and 1 case (5%), respectively. Fisher’s exact test revealed a significant correlation between MDM2 gene amplification and myxoid stroma (p = 0.0194). No parameters showed any association with the anatomical location of the tumours. It was suggested that myxoid histology of intimal sarcoma may be associated with MDM2 gene amplification and that intimal sarcoma may be divided into myxoid and non-myxoid types.

    DOI: 10.1007/s00428-022-03293-9

    Web of Science

    Scopus

    PubMed

  • 下行結腸原発Histiocytic sarcomaの1例 Reviewed

    阿部 千恵, 米田 玲子, 毛利 太郎, 山田 優衣, 山田 裕一, 小田 義直

    診断病理   39 ( 1 )   56 - 61   2022.1   ISSN:1345-6431

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    Histiocytic sarcoma(HS)は稀な疾患で、とりわけ結腸発生例は数例しか報告がない。今回我々は下行結腸に発生したHSの1例を報告する。症例は47歳女性。内視鏡検査で下行結腸に腫瘤を認め、CTでリンパ節と肝臓への転移が疑われた。腸重積を来しており、左側結腸切除術が施行された。腫瘍は軟らかく淡褐色充実性で、組織学的に上皮様または組織球様の異型細胞がびまん性に増殖し、血球貪食像もみられた。免疫染色で異型細胞はCD68とCD163に陽性を示した。以上の所見よりHSと診断した。(著者抄録)

  • Clinicopathological and prognostic significance of H3K27 methylation status in malignant peripheral nerve sheath tumor: correlation with skeletal muscle differentiation. Reviewed International journal

    Ito Y, Kohashi K, Endo M, Yoshimoto M, Ishihara S, Toda Y, Susuki Y, Kawaguchi K, Furukawa H, Tateishi Y, Yamada Y, Kinoshita I, Mori T, Yamamoto H, Nakashima Y, Oda Y

    Virchows Archiv   479 ( 6 )   1233 - 1244   2021.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Malignant peripheral nerve sheath tumor (MPNST) is a very aggressive peripheral nerve sheath-derived sarcoma, which is one of the most difficult tumors to diagnose due to its wide spectrum of histological findings and lack of specific immunohistochemical markers. Recently, it has been reported that losses of expression of H3K27me3 and H3K27me2 caused by PRC2 dysfunction may be useful diagnostic markers for MPNST, but there is no consensus on their clinicopathological significance. Here, we investigated the relationship between loss of H3K27 methylation and various parameters and clarified the clinicopathological significance of such loss. We analyzed the clinicopathological and immunohistochemical features in 84 MPNST cases. Complete losses of H3K27me3 and H3K27me2 were observed in 37 (44%) and 29 (35%) cases, respectively. Losses of H3K27me3 and H3K27me2 were significantly correlated with myogenic immunopositivity (H3K27me3 vs. desmin, P = 0.0051; H3K27me3 vs. myogenin, P = 0.0009; H3K27me2 vs. myogenin, P = 0.042). Meanwhile, there were significant correlations between preservation of immunohistochemical neurogenic markers and intact H3K27me3 and H3K27me2 (H3K27me3 vs. S-100 protein, P = 0.0019; H3K27me3 vs. SOX10, P = 0.014; H3K27me2 vs. S-100 protein, P = 0.0011; H3K27me2 vs. SOX10, P = 0.0087). In multivariate analysis, local recurrence, distant metastasis, high FNCLCC grade, and loss of SOX10 expression were independent prognostic factors for overall survival. H3K27me3 and H3K27me2 expression was retained in all 26 cases of rhabdomyosarcoma non-alveolar subtype. In conclusion, we suggest that H3K27me3 and H3K27me2 immunonegativity is useful but not definitive for diagnosing MPNST. Complete loss of H3K27 methylation may be involved in aggressive transdifferentiation from neural differentiation to skeletal muscle differentiation in MPNST.

    DOI: 10.1007/s00428-021-03189-0.

  • Prognostic implication of desmoplastic stroma in synovial sarcoma: A histological review. Invited Reviewed International journal

    Toda Y, Yamada Y, Kohashi K, Ishihara S, Ito Y, Susuki Y, Kawaguchi K, Kinoshita I, Kiyozawa D, Mori T, Kuboyama Y, Tateishi Y, Yamamoto H, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Nakashima Y, Mawatari M, Oda Y

    Pathology - Research and Practice   228 ( 153668 )   2021.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Synovial sarcoma (SS) is a malignant soft tissue neoplasm harboring SS18-SSX fusion gene and is histologically characterized by spindle cells and epithelial components. Some investigations have demonstrated that desmoplastic reaction (DR) is an independent prognostic factor of cancers. However, it remains unknown whether DR is of predictive value for the prognosis of synovial sarcoma patients. Here, we reviewed the clinical and histological findings of 88 patients with SS. We defined DR as hyalinized collagenous structures and classified the degree of DR as follows: none, mild, moderate, and severe. Overall, 23 SS cases (24%) showed moderate or severe DR histologically. Statistically, the cases with moderate or severe degree of DR showed poorer prognosis than those with no or mild DR (local recurrence: P = 0.0059, distant metastasis: P = 0.0002, tumor death: P = 0.0382). The findings of the study suggest that the DR of synovial sarcoma could be an important prognostic factor.

    DOI: 10.1016/j.prp.2021.153668.

  • Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution. Reviewed International journal

    Tateishi Y, Yamada Y, Katsuki M, Nagata T, Yamamoto H, Kohashi K, Koga Y, Hashisako M, Kiyozawa D, Mori T, Kuboyama Y, Kakinokizono A, Miyazaki Y, Yamaguchi A, Tsutsui H, Ninomiya T, Naiki H, Oda Y

    Pathology - Research and Practice   227 ( 153635 )   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution.

    DOI: 10.1016/j.prp.2021.153635.

  • The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma. Reviewed International journal

    Ishihara S, Iwasaki T, Kohashi K, Yamada Y, Toda Y, Ito Y, Susuki Y, Kawaguchi K, Takamatsu D, Kawatoko S, Kiyozawa D, Mori T, Kinoshita I, Yamamoto H, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Nakashima Y, Oda Y

    Journal of Cancer Research and Clinical Oncology   147 ( 7 )   2003 - 2011   2021.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: Undifferentiated pleomorphic sarcoma (UPS) is a sarcoma with a poor prognosis. A clinical trial, SARC028, revealed that treatment with anti-PD-1 drugs was effective against UPS. Studies have reported that UPS expresses PD-L1, sometimes strongly (≥ 50%). However, the mechanism of PD-L1 expression in UPS has remained unclear. CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) was identified as a novel regulator of PD-L1 expression. The positive relationship between PD-L1 and CMTM6 has been reported in several studies. The aim of this study was thus to examine CMTM6 expression in UPS and evaluate the relationship between PD-L1 and CMTM6 in this disease.
    Materials and methods: Fifty-one primary UPS samples were subjected to CMTM6 and PD-L1 immunostaining. CMTM6 expression was assessed using proportion and intensity scores. CMTM6 gene copy number was also evaluated using a real-time PCR-based copy number assay. We also analyzed the mRNA expression and copy number variation of PD-L1 and CMTM6 in The Cancer Genome Atlas (TCGA) data.
    Results: TCGA data indicated that the mRNAs encoded by genes located around 3p22 were coexpressed with CMTM6 mRNA in UPS. Both proportion and intensity scores of CMTM6 positively correlated with strong PD-L1 expression (≥ 50%) (both p = 0.023). CMTM6 copy number gain increased CMTM6 expression. Patients with UPS with a high CMTM6 intensity score had a worse prognosis for overall survival.
    Conclusions: UPS showed variation in CMTM6 copy number and CMTM6 expression. CMTM6 expression was significantly correlated with PD-L1 expression, especially with strong PD-L1 expression.

    DOI: 10.1007/s00432-021-03616-4.

  • A validation study of whole slide imaging for primary diagnosis of lymphoma. Reviewed International journal

    Amin S, Mori T, Itoh T

    Pathology International   69 ( 6 )   341 - 349   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Whole slide imaging (WSI) is being increasingly used worldwide. Although previous studies have asserted the validity of WSI diagnosis, they have primarily targeted only small specimens and excluded cases requiring immunohistochemistry or special staining, such as lymphoma. The purpose of this study was to evaluate the accuracy of WSI diagnosis of lymphoma, for which 240 biopsies and resections of lymphoma cases were selected from the study set of lymphomas. All slides including H&E, immunohistochemical and special staining were digitized using a WSI image scanner. An experienced pathologist performed the WSI diagnoses, which were compared with original diagnoses based on light microscopic examinations. Discrepancy between the two interpretations were classified into three categories: concordance, minor discrepancy (no clinical significance), and major discrepancy (with clinical significance). Overall concordance between the light microscopic and WSI diagnosis was found in 223 cases (92.92%; 95%CI = 88.90-95.82), minor discrepancy in fifteen (6.25%; 95%CI = 3.54-10.10), and major discrepancy in two (0.83%; 95%CI = 0.10-2.98). Diagnosis of lymphoma using WSI appeared to be mostly accurate, suggesting that WSI may be a reliable technology for the diagnosis of lymphoma.

    DOI: 10.1111/pin.12808.

▼display all

Books

  • 骨・軟部腫瘍 臨床・画像・病理

    Role:Joint author)

    診断と治療社  2025.4 

     More details

    Total pages:326   Responsible for pages:196-199, 202, 203   Language:Japanese   Book type:Textbook, survey, introduction

  • 歯学生のための基礎病理学

    Role:Joint authorXII 骨軟部組織の疾患)

    医歯薬出版株式会社  2024.5 

     More details

    Total pages:403   Responsible for pages:335-344   Language:Japanese   Book type:Textbook, survey, introduction

Presentations

▼display all

MISC

Professional Memberships

  • 日本病理学会

  • 日本臨床細胞学会

  • 日本癌学会

  • 日本臨床検査医学会

Committee Memberships

  • 日本病理学会   Councilor   Domestic

    2023.4 - Present   

Academic Activities

  • Pathology International International contribution

    Role(s): Peer review

    2025.1

     More details

    Type:Peer review 

Educational Activities

  • 学生が病理学の理解を得られるよう、分かりやすい講義を行うとともに、病理学研究の魅力を伝える。また、大学院生の指導を通じて、さらなる研究成果を挙げられるように努める。

Class subject

  • 病因と病態II

    2024.4 - 2024.9   First semester

  • 系統医学Ⅱ:病理学(総論)

    2024.4 - 2024.9   First semester

  • 系統医学Ⅱ:病理学(総論)

    2023.4 - 2023.9   First semester

  • 病因と病態II

    2023.4 - 2023.9   First semester

Outline of Social Contribution and International Cooperation activities

  • I work to promote the Japan Bone and Soft Tissue Tumor Club of Japan (BTC) as a general affairs officer. I am also involved in consultative diagnosis of difficult cases from other institutions and contributes to the improvement of the accuracy of bone and soft tissue pathology diagnosis in Japan.

Social Activities

  • 日本骨軟部腫瘍研究会

    Role(s):Organizing member

    2022.1 - Present

Specialized clinical area

  • Biological Sciences / Medicine, Dentistry and Pharmacy / Basic Medicine / Human Pathology

Clinician qualification

  • Preceptor

    The Japanese Society of Clinical Cytology

  • Preceptor

    The Japanese Society of Pathology

  • Certifying physician

    Japanese Society of Laboratory Medicine(JSLM)

Year of medical license acquisition

  • 2013